| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.4M | — | -26.6% |
| Cost of Revenue | $1.2M | — | +1.7% |
| Gross Profit | $1.2M | — | -43.4% |
| R&D Expense | $149K | — | +39.8% |
| SG&A Expense | $1.0M | — | +16.4% |
| Operating Income | -$1.3M | — | -1914.9% |
| Net Income | -$1.3M | — | -1096.2% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.3M | -20.5% | -18.1% |
| Accounts Receivable | $1.3M | -10.3% | -24.7% |
| Inventory | $832K | -5.0% | +15.0% |
| Current Assets | $3.9M | -15.3% | -14.1% |
| Total Assets | $17.2M | -3.6% | -2.2% |
| Current Liabilities | $4.4M | +11.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$72K | — | -1315.2% |
| Capital Expenditures | $205K | — | +59.2% |
| Investing Cash Flow | -$205K | — | -59.2% |
| Financing Cash Flow | -$57K | — | +62.3% |
| Free Cash Flow | -$278K | — | -107.2% |
| -4.0% |
| Total Liabilities | $14.5M | +2.8% | +9.9% |
| Stockholders' Equity | $2.6M | -28.3% | -39.0% |